Clinical features of post-COVID syndrome in pediatric patients: a literature review

Authors

DOI:

https://doi.org/10.14739/2310-1210.2026.3.342597

Keywords:

viral infection, post-COVID-19 syndrome, NT-proBNP, D-dimer, endothelial dysfunction, cytokine storm, multisystem inflammatory syndrome, viral carditis

Abstract

In recent years, the global medical and scientific community has continued to investigate COVID-19. Scientific attention, however, has shifted beyond the emergence of novel variants to include the development of postCOVID syndrome, which may occur in both adults and children.

Aim. To characterize the features of development and clinical manifestations of post-COVID-19 syndrome in children based on an analysis of the scientific literature.

Materials and methods. A narrative review of studies published between 2020 and 2025 retrieved from PubMed, Scopus, Web of Science, Google Scholar, ScienceDirect, UpToDate, and selected Ukrainian peer-reviewed journals was conducted. Eligible studies addressed clinical features, laboratory biomarkers, echocardiography and cardiac MRI findings, multisystem inflammatory syndrome in children (MIS-C), and coagulopathy in pediatric patients.

Results. The reported prevalence of pediatric post-COVID-19 syndrome ranges from 4 % to 66 %. Among affected children, 10–27 % exhibit persistent symptoms 2–5 months after acute recovery. Common manifestations include fatigue, dyspnea, headache, cognitive complaints, anxiety, tachycardia, and sleep disturbance. Cardiac alterations were reported in 25–75 % of cases across included studies; findings encompass transient myocardial dysfunction, reduced left-ventricular ejection fraction, left ventricular dilatation, and arrhythmias. In MIS-C patients, NT-proBNP and troponin I elevations and systolic impairment are more pronounced compared to non-MIS-C post-COVID-19 cases. Coagulopathy is characterized by increased D-dimer and fibrinogen levels with a relatively low rate of overt thrombosis. Correlations among D-dimer, NT-proBNP, and ferritin levels highlight endothelial dysfunction as a central pathophysiologic driver.

Conclusions. Pediatric post-COVID-19 syndrome is a multisystem entity dominated by endothelial-inflammatory mechanisms. NT-proBNP, D-dimer, and troponin I, together with echocardiography and cardiac MRI, are essential for risk stratification and long-term follow-up. Standardized monitoring protocols and long-term outcome studies are urgently needed.

Author Biographies

O. V. Liamtseva, Zaporizhzhia State Medical and Pharmaceutical University

MD, PhD student at the Department of Faculty Pediatric

S. M. Nedelska, Zaporizhzhia State Medical and Pharmaceutical University

MD, PhD, DSc, Professor, Head of the Department of Faculty Pediatric

References

  1. Ludvigsson JF. Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr. 2020;109(6):1088-95. doi: https://doi.org/10.1111/apa.15270
    | |
  2. Radtke T, Ulyte A, Puhan MA, Kriemler S. Long-term Symptoms After SARS-CoV-2 Infection in Children and Adolescents. JAMA. 2021;326(9):869-71. doi: https://doi.org/10.1001/jama.2021.11880
    | |
  3. Palacios S, Krivchenia K, Eisner M, Young B, Ramilo O, Mejias A, et al. Long-term pulmonary sequelae in adolescents post-SARS-CoV-2 infection. Pediatr Pulmonol. 2022;57(10):2455-63. doi: https://doi.org/10.1002/ppul.26059
    | |
  4. Behnood SA, Shafran R, Bennett SD, Zhang A, O’Mahoney LL, Stephenson TJ, et al. Persistent symptoms following SARS-CoV-2 infection amongst children and young people: A meta-analysis of controlled and uncontrolled studies. J Infect. 2022;84(2):158-70. doi: https://doi.org/10.1016/j.jinf.2021.11.011
    | |
  5. Lopez-Leon S, Wegman-Ostrosky T, Ayuzo Del Valle NC, Perelman C, Sepulveda R, Rebolledo PA, et al. Long-COVID in children and adolescents: a systematic review and meta-analyses. Sci Rep. 2022;12(1):9950. doi: https://doi.org/10.1038/s41598-022-13495-5
    | |
  6. Maddux AB, Berbert L, Young CC, Feldstein LR, Zambrano LD, Kucukak S, et al. Health Impairments in Children and Adolescents After Hospitalization for Acute COVID-19 or MIS-C. Pediatrics. 2022;150(3):e2022057798. doi: https://doi.org/10.1542/peds.2022-057798
    | |
  7. Funk AL, Kuppermann N, Florin TA, Tancredi DJ, Xie J, Kim K, et al. Post-COVID-19 Conditions Among Children 90 Days After SARS-CoV-2 Infection. JAMA Netw Open. 2022;5(7):e2223253. doi: https://doi.org/10.1001/jamanetworkopen.2022.23253
    | |
  8. Doshi JA, Sheils NE, Buresh J, Quinicot E, Islam N, Chen Y, et al. SARS-CoV-2 Sequelae and Postdischarge Health Care Visits Over 5 Months Follow-up Among Children Hospitalized for COVID-19 or MIS-C. Pediatr Infect Dis J. 2022;41(12):e513-e516. doi: https://doi.org/10.1097/INF.0000000000003692
    | |
  9. Greenhalgh T, Knight M, A’Court C, Buxton M, Husain L. Management of post-acute covid-19 in primary care. BMJ. 2020;370:m3026. doi: https://doi.org/10.1136/bmj.m3026
    | |
  10. Zimmermann P, Pittet LF, Curtis N. How Common is Long COVID in Children and Adolescents? Pediatr Infect Dis J. 2021;40(12):e482-7. doi: https://doi.org/10.1097/INF.0000000000003328
    | |
  11. Sokolowska M, Lukasik ZM, Agache I, Akdis CA, Akdis D, Akdis M, et al. Immunology of COVID-19: Mechanisms, clinical outcome, diagnostics, and perspectives-A report of the European Academy of Allergy and Clinical Immunology (EAACI). Allergy. 2020;75(10):2445-76. doi: https://doi.org/10.1111/all.14462
    | |
  12. Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8(4):420-2. doi: https://doi.org/10.1016/S2213-2600(20)30076-X
    | |
  13. Tian S, Hu W, Niu L, Liu H, Xu H, Xiao SY. Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer. J Thorac Oncol. 2020;15(5):700-4. doi: https://doi.org/10.1016/j.jtho.2020.02.010
    | |
  14. Sinha P, Matthay MA, Calfee CS. Is a “Cytokine Storm” Relevant to COVID-19? JAMA Intern Med. 2020;180(9):1152-4. doi: https://doi.org/10.1001/jamainternmed.2020.3313
    | |
  15. Buonsenso D, Munblit D, De Rose C, Sinatti D, Ricchiuto A, Carfi A, et al. Preliminary evidence on long COVID in children. Acta Paediatr. 2021;110(7):2208-11. doi: https://doi.org/10.1111/apa.15870
    | |
  16. Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Lond). 2021;53(10):737-54. doi: https://doi.org/10.1080/23744235.2021.1924397
    | |
  17. COVID-19 rapid guideline: managing the long-term effects of COVID-19 [Internet]. NICE. [cited 2026 May 4]. Available from: https://www.nice.org.uk/guidance/ng188
  18. Perego E, Callard F, Stras L, Melville-Jóhannesson B, Pope R, Alwan N. Why the Patient-Made Term “Long Covid” is needed. Wellcome Open Res. 2020. p. 224. Available from: https://doi.org/10.12688/wellcomeopenres.16307.1
  19. Walsh-Messinger J, Manis H, Vrabec A, Sizemore J, Bishof K, Debidda M, et al. The kids are not alright: A preliminary report of Post-COVID syndrome in university students. J Am Coll Health. 2023;71(5):1367-73. doi: https://doi.org/10.1080/07448481.2021.1927053
    | |
  20. Boyarchuk O, Perestiuk V, Kosovska T, Volianska L. Coagulation profile in hospitalized children with COVID-19: pediatric age dependency and its impact on long COVID development. Front Immunol. 2024;15:1363410. doi: https://doi.org/10.3389/fimmu.2024.1363410
    | |
  21. Mahase E. Long covid could be four different syndromes, review suggests. BMJ. 2020;371:m3981. doi: https://doi.org/10.1136/bmj.m3981
    | |
  22. Taquet M, Luciano S, Geddes JR, Harrison PJ. Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA. Lancet Psychiatry. 2021;8(2):130-40. doi: https://doi.org/10.1016/S2215-0366(20)30462-4
    | |
  23. Nehme M, Braillard O, Alcoba G, Aebischer Perone S, Courvoisier D, Chappuis F, et al. COVID-19 Symptoms: Longitudinal Evolution and Persistence in Outpatient Settings. Ann Intern Med. 2021;174(5):723-5. doi: https://doi.org/10.7326/M20-5926
    | |
  24. Crook H, Raza S, Nowell J, Young M, Edison P. Long covid-mechanisms, risk factors, and management. BMJ. 2021;374:n1648. doi: https://doi.org/10.1136/bmj.n1648
    | |
  25. Dalan R, Bornstein SR, El-Armouche A, Rodionov RN, Markov A, Wielockx B, et al. The ACE-2 in COVID-19: Foe or Friend? Horm Metab Res. 2020;52(5):257-63. doi: https://doi.org/10.1055/a-1155-0501
    | |
  26. Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601-15. doi: https://doi.org/10.1038/s41591-021-01283-z
    | |
  27. Jimeno-Almazán A, Pallarés JG, Buendía-Romero Á, Martínez-Cava A, Franco-López F, Sánchez-Alcaraz Martínez BJ, et al. Post-COVID-19 Syndrome and the Potential Benefits of Exercise. Int J Environ Res Public Health. 2021;18(10):5329. doi: https://doi.org/10.3390/ijerph18105329
    | |
  28. Zabeida A, Winikoff R, Pelland-Marcotte MC, Charlebois J, Sabapathy C. COVID-19-associated coagulopathy in children: A multicenter observational cohort study. Pediatr Blood Cancer. 2023;70(1):e30079. doi: https://doi.org/10.1002/pbc.30079
    | |
  29. Madjid M, Safavi-Naeini P, Solomon SD, Vardeny O. Potential Effects of Coronaviruses on the Cardiovascular System: A Review. JAMA Cardiol. 2020;5(7):831-40. doi: https://doi.org/10.1001/jamacardio.2020.1286
    | |
  30. Matta J, Wiernik E, Robineau O, Carrat F, Touvier M, Severi G, et al. Association of Self-reported COVID-19 Infection and SARS-CoV-2 Serology Test Results With Persistent Physical Symptoms Among French Adults During the COVID-19 Pandemic. JAMA Intern Med. 2022;182(1):19-25. doi: https://doi.org/10.1001/jamainternmed.2021.6454
    | |
  31. Patel T, Kelleman M, West Z, Peter A, Dove M, Butto A, et al. Comparison of Multisystem Inflammatory Syndrome in Children-Related Myocarditis, Classic Viral Myocarditis, and COVID-19 Vaccine-Related Myocarditis in Children. J Am Heart Assoc. 2022;11(9):e024393. doi: https://doi.org/10.1161/JAHA.121.024393
    | |
  32. Hliebova LP, Andrushchenko IV. [Multisystem inflammatory syndrome in children (COVID-19): cardiovascular complications]. Ukrainian Medical Journal. 2026;(3). Ukrainian. doi: https://doi.org/10.32471/umj.1680-3051.275823
  33. Guner Ozenen G, Akaslan Kara A, Kiymet E, Boncuoglu E, Sahinkaya S, Cem E, et al. The Evaluation of Troponin I Levels and Myocarditis in Children with COVID-19: A Pediatric Single-Center Experience. Pediatr Cardiol. 2023;44(4):873-81. doi: https://doi.org/10.1007/s00246-022-03017-5
    | |
  34. Usachova OV, Aleksiuk DV. Multisystem pediatric inflammatory syndrome associated with COVID-2019 in the Zaporizhzhia region. Pathologia. 2023;20(3):289-94. doi: https://doi.org/10.14739/2310-1237.2023.3.286445
    |
  35. Carretta DM, Silva AM, D’Agostino D, Topi S, Lovero R, Charitos IA, et al. Cardiac Involvement in COVID-19 Patients: A Contemporary Review. Infect Dis Rep. 2021;13(2):494-517. doi: https://doi.org/10.3390/idr13020048
    | |
  36. Mishchuk V, Lytvyn H, Pryimakova V, Ivaniushko O, Stasiv M, Kuzminov Y. Post-COVID-19 cardiovascular complications in children. Description of clinical cases. Child`s health. 2024;19(6):375-81. doi: https://doi.org/10.22141/2224-0551.19.6.2024.1742
  37. Pypa LV, Odarchuk IV, Lysytsia YM, Ruda VI, Krenov KY. Polymorphism of clinical manifestations, experience of diagnosis and treatment of multisystem inflammatory syndrome associated with COVID-19 in children. Modern Pediatrics. Ukraine. 2022;(8):37-44. doi: https://doi.org/10.15574/SP.2022.128.37
    |
  38. Jiehao C, Jin X, Daojiong L, Zhi Y, Lei X, Zhenghai Q, et al. A Case Series of Children With 2019 Novel Coronavirus Infection: Clinical and Epidemiological Features. Clin Infect Dis. 2020;71(6):1547-51. doi: https://doi.org/10.1093/cid/ciaa198
    | |
  39. Lu X, Zhang L, Du H, Zhang J, Li YY, Qu J, et al. SARS-CoV-2 Infection in Children. N Engl J Med. 2020;382(17):1663-5. doi: https://doi.org/10.1056/NEJMc2005073
    | |
  40. Petritsa NA, Lukyanenko NS, Kech NR. [Specifics of clinical manifestations of post-COVID-19 syndrome in children]. Modern Pediatrics. Ukraine. 2024;(4):48-55. Ukrainian. doi: https://doi.org/10.15574/SP.2024.140.48
    |
  41. Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594(7862):259-64. doi: https://doi.org/10.1038/s41586-021-03553-9
    | |
  42. Das BB, Akam-Venkata J, Abdulkarim M, Hussain T. Parametric Mapping Cardiac Magnetic Resonance Imaging for the Diagnosis of Myocarditis in Children in the Era of COVID-19 and MIS-C. Children (Basel). 2022;9(7):1061. doi: https://doi.org/10.3390/children9071061
    | |
  43. Kuehn BM. Post-COVID-19 Symptoms Were Worse Than Cancer’s Effects. JAMA. 2021;326(8):692. doi: https://doi.org/10.1001/jama.2021.12353
    | |
  44. Kaushik S, Aydin SI, Derespina KR, Bansal PB, Kowalsky S, Trachtman R, et al. Multisystem Inflammatory Syndrome in Children Associated with Severe Acute Respiratory Syndrome Coronavirus 2 Infection (MIS-C): A Multi-institutional Study from New York City. J Pediatr. 2020;224:24-9. doi: https://doi.org/10.1016/j.jpeds.2020.06.045
    | |
  45. Herridge MS, Moss M, Hough CL, Hopkins RO, Rice TW, Bienvenu OJ, et al. Recovery and outcomes after the acute respiratory distress syndrome (ARDS) in patients and their family caregivers. Intensive Care Med. 2016;42(5):725-38. doi: https://doi.org/10.1007/s00134-016-4321-8
    | |

Downloads

Additional Files

Published

2026-06-11

How to Cite

1.
Liamtseva OV, Nedelska SM. Clinical features of post-COVID syndrome in pediatric patients: a literature review. Zaporozhye Medical Journal [Internet]. 2026Jun.11 [cited 2026Jun.11];28(3):282-8. Available from: https://zmj.zsmu.edu.ua/article/view/342597

Issue

Vol. 28 No. 3 (2026): Zaporozhye Medical Journal

Section

Review

License

Copyright (c) 2026 O. V.Liamtseva, S. M.Nedelska

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.  Лицензия Creative Commons